Clinical Trial Update: Efficacy and Safety of Pirfenidone Treatment in HPS-ILD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of pirfenidone in Hermansky-Pudlak Syndrome–associated interstitial lung disease is reported with un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hermansky-pudlak Syndrome
• Interstitial Lung Disease

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Jesse Roman | Conditions: Hermansky Pudlak Syndrome, Interstitial Lung Disease | Phase 2 | Status: UNKNOWN